Pharmaceutical Law & Industry Report® Index-Summary

IDAHO

– Actavis Medicaid pricing settlement (Idaho Dist. Ct.), 714
– Sandoz Medicaid pricing settlement (Idaho Dist. Ct.), 1341

ILLUVIEN

– Eye drug application, 1634

INCRELAX

– Growth failure treatment promotional materials, 1442

INDIA

– Chinese partnership, 1639
– Generic drugs

– – EU seizures, 664; deal with EU, 1382
– – Global brand-building campaign, 1565

– Patents on drugs, Analysis & Perspective, 46
– Price controls, 1163

INDIANA

– Health care fraud enforcement efforts, 1115

INFLUENZA

– Emergency drug supplies, FDA guidance, 71; information sought, 1349

INFORMATION NETWORKS AND TECHNOLOGY

– Clinical trials, Alzheimer's public database, 793
– Pharmacies, database of patient services, 171

INTEGRILIN

– Anti-clotting drug infringement suit (D. Del.), 551

INTELLECTUAL PROPERTY

– Biologics process/platform, 1257
– Patents

See PATENTS

– Russia, improved protection, 1356
– Special 301 list criticized, 964
– Trade secrets theft indictment against Bristol-Myers ex-worker (N.D.N.Y.), 183

INTERNATIONAL DEVELOPMENTS

– Counterfeit drugs and developing countries, 731
– Imported drugs

– – Conspiracy to reimport (M.D. Pa.), 650
– – Counterfeit drugs, 595
– – Developing countries and generics, 1444
– – Mont., Canadian drug imports, 362; pilot program with N.D., 525
– – Pricing, Canadian agency jurisdiction, 533; appeal, 570
– – Safety, Senate hearings, 327

– Pan American Health Organization and FDA, 1317
– Russia, collaboration with PTO, 796
– Tariff elimination, 1228
– Trans-Pacific Partnership, 1196
– Trends

– – Growth of global market, 1320
– – Patents, decline in international findings, 221

INTERNET

– Amag webpages, FDA scrutiny, 1378
– FDA

– – FDA-TRACK launch, 1149
– – Transparency initiative, website launch, 70

– Fla. drug pricing website, 822
– Tamiflu fakes sold on web, 820
– Tasigna website, FDA letter, 1061

INTUNIV

– ADHD starter kit, FDA says misleading, 899

INVIRASE

– HIV drug and heart risk, 1376

IOWA

– Medicaid AWP suit dismissal (D. Mass.), 1465

IPLEX

– Investigational drug, access (N.D.N.Y.), 1399

ITALY

– Latanoprost antitrust probe, 1479
– OTC ads, 1236